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OBJECTIVE — To examine sex and racial/ethnic differences in cardiovascular risk factor
treatment and control among individuals with diabetes in the Multi-Ethnic Study of Atheroscle-
rosis (MESA).
RESEARCH DESIGN AND METHODS — This study was an observational study ex-
amining mean levels of cardiovascular risk factors and proportion of subjects achieving treat-
ment goals.
RESULTS — The sample included 926 individuals with diabetes. Compared with men,
women were 9% less likely to achieve LDL cholesterol 130 mg/dl (adjusted prevalence ratio
0.91 [0.83–0.99]) and systolic blood pressure (SBP) 130 mmHg (adjusted prevalence ratio
0.91 [0.85–0.98]). These differences diminished over time. A lower percentage of women used
aspirin (23 vs. 33%; P  0.001). African American and Hispanic women had higher mean levels
of SBP and lower prevalence of aspirin use than non-Hispanic white women.
CONCLUSIONS — Women with diabetes had unfavorable cardiovascular risk factor pro-
ﬁlescomparedwithmen.AfricanAmericanandHispanicwomenhadlessfavorableproﬁlesthan
non-Hispanic white women.
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P
opulation-based health survey data
suggest that sex and racial/ethnic
disparities are present in diabetes
process of care measures and cardiovas-
cular risk factor control (1–9). Available
data also indicate that sex-speciﬁc race/
ethnicitydifferencesarepresentincardio-
vascularriskfactorcontrol,butthesedata
are limited to Medicare and Veterans’
Hospital patient populations (5,10–13).
We therefore performed analyses of par-
ticipants with diabetes in the Multi-
Ethnic Study of Atherosclerosis (MESA)
to examine sex and sex-speciﬁc racial/
ethnic differences in cardiovascular risk
factor treatment and control.
RESEARCH DESIGN AND
METHODS— MESA is a multicenter
cohort study of 6,814 men and women
age45–84yearswithnoclinicalevidence
ofcardiovasculardiseaseattimeofenroll-
ment (14). Four MESA exam periods oc-
curred between 2000 and 2007. The
study was approved by the Institutional
Review Board at all participating institu-
tions,andallMESAparticipantsprovided
informed consent. Criteria for recruit-
ment, data collection methods, and labo-
ratory techniques have been previously
described (14). Participants were classi-
ﬁed as having diabetes if at exam 1 they
hadafastingplasmaglucose126mg/dl,
used oral hypoglycemic agents and/or in-
sulin,orreportedaphysiciandiagnosisof
diabetes.
Statistical analysis
Multivariate models were used to calcu-
latepredictedmeansforlipid,bloodpres-
sure, and A1C levels. Prevalence ratios
(PRs) were calculated for percentages of
participants achieving cardiovascular risk
factor goals using binomial regression,
with adjustment for age, MESA site, so-
cioeconomic status variables, and either
sex or race/ethnicity. Potential effects of
selective attrition on longitudinal results
were examined using t tests to determine
if participants lost to follow-up had
higher mean cardiovascular risk factor
levels compared with those retained in
thestudy.Analyseswereperformedusing
SAS version 9.1.
RESULTS— Of 926 MESA partici-
pants with diabetes at exam 1 (2000–
2002), 48% were women. Four racial/
ethnic groups were represented (19%
non-Hispanicwhite[NHW],38%African
American, 31% Hispanic, and 12% Chi-
nese). Compared with men, women were
more likely to report gross family income
$20,000 (42 vs. 26%) and less than
high school education (33 vs. 27%).
Cross-sectional data
Atexam1,afteradjustmentforage,MESA
site, and race/ethnicity, systolic blood
pressure (SBP) was 3.5 mmHg higher
amongwomenthanmen(133.7vs.130.2
mmHg, P  0.01). LDL cholesterol and
A1Cdidnotdifferbysex.Afteradditional
adjustment for socioeconomic status,
there was no sex difference in mean SBP
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women had signiﬁcantly higher mean
SBP values than NHW women. A signiﬁ-
cantly lower percentage of women were
taking aspirin (Table 1). Hispanic women
reported taking less aspirin than NHW
women.
A lower percentage of women
achieved LDL cholesterol 130 mg/dl
(69.4 vs. 77.1%, P  0.01) and SBP
130 mmHg (42.2 vs. 57.8%, P 
0.002) compared with men. Women
were 9% less likely to achieve LDL cho-
lesterol130mg/dlthanmen(adjusted
PR0.91[0.85–0.98])and9%lesslikely
to achieve SBP 130 mmHg (adjusted
PR 0.91 [0.83–0.99]). African Ameri-
canandHispanicwomenwere31%(ad-
justed PR 0.69 [0.51–0.91]) and 30%
(adjusted PR 0.70 [0.52–0.95]) less
likely, respectively, to achieve blood
pressure 130/80 mmHg compared
with NHW women.
Longitudinal data
Of926subjectswithdiabetesatexam1,
802 completed exam 2, 751 exam 3,
and 719 exam 4. At exam 4, LDL cho-
lesterol (96.4 vs. 94.6 mg/dl, P  0.54)
and SBP (130.3 vs. 127.6 mmHg, P 
0.11) did not differ between women
and men. At exam 4, there was no dif-
ference in the percentage of women
achieving LDL cholesterol 130 mg/dl
(adjusted PR 0.97 [0.91–1.04]) or
SBP 130 mmHg (adjusted PR 0.95
[0.88–1.02]) compared with men.
AfricanAmericanwomenwere33%less
likely to achieve blood pressure
130/80 mmHg (adjusted PR 0.67
[0.49–0.91]) compared with NHW
women. Although women reported
higher antihypertensive and lipid-
lowering medication use compared
with men at exam 1, there was no dif-
ference at exam 4 in antihypertensive
(80 vs. 75%, P  0.20) or lipid-
lowering medication (51 vs. 49%, P 
0.70) use. Aspirin use increased for
bothsexesfrom2000to2007;however,
women remained less likely to report
aspirin use at exam 4 compared with
men(44vs.57%,P  0.05).Aspirinuse
remained lower for African American
and Hispanic women compared with
NHW women (51 and 39% vs. 58%,
respectively).
CONCLUSIONS— Among MESA
participants with diabetes, at the baseline
exam, a lower proportion of women
achieved consensus treatment targets for
SBP and LDL cholesterol, after adjust-
ment for covariates. These differences
were observed despite a greater reported
use of blood pressure and lipid-lowering
medications among women. African
AmericanandHispanicwomenhadlower
proportions achieving consensus treat-
ment goals for blood pressure and less re-
ported use of aspirin compared with
NHW women. The sex difference in LDL
cholesterol and SBP control diminished
over time.
Our ﬁndings are consistent with pre-
vious reports showing sex and racial/
ethnic differences in cardiovascular risk
factor control among individuals with di-
abetes(2,12,13,15).Inconsistentﬁndings
have been reported regarding sex and ra-
cial/ethnic differences in use of medica-
tions for management of cardiovascular
factors (3,4,8).
Thereareseveralpotentialmechanisms
for the sex and racial/ethnic differences we
observed. Regression adjustment for socio-
economic status variables eliminated the
signiﬁcantsexdifferenceinmeanSBP.So-
cioeconomic variables may correlate with
access to high-quality medical care and
with personal behaviors that inﬂuence
risk factor levels, including medication
adherence, diet, and exercise. Our ﬁnd-
ings may also indicate a disparity in med-
ication titration by physicians.
There are several limitations to our
study.Informationonmedicationusewas
self-reported and patient adherence was
Table 1—Cardiovascular disease risk factors and aspirin use for participants with diabetes, 2000–2002
n
LDL cholesterol
(mg/dl) SBP (mmHg)
Diastolic blood
pressure (mmHg)
Pulse pressure
(mmHg) A1C (%) Aspirin (%)
Sex
Women 448 112.6  2.31 133.3  1.37 68.6  0.64* 64.7  1.06* 7.38  0.12 97 (23)*
Men 478 109.6  2.14 131.1  1.26 75.2  0.58 55.9  0.97 7.44  0.11 155 (33)
Race/ethnicity and sex
subgroups
NHW 176 110.5  3.13 129.9  91.83 69.9  0.85 60.0  1.42 7.18  0.16 64 (38)
Women 72 110.3  4.49 127.9  2.67 65.9  1.24 62.0  2.06 7.28  0.23 20 (29)
Men 104 110.3  3.92 130.8  2.27 73.6  1.05 57.1  1.75 7.14  0.19 44 (44)
African American 356 112.2  2.51 135.6  1.49†† 74.7  0.69††† 60.9  1.16 7.65  0.13†† 96 (28)†
Women 184 116.3  3.18 136.8  1.89‡‡ 72.1  0.88 64.7  1.46 7.56  1.16 42 (24)
Men 172 108.2  3.18 134.4  1.89 77.2  0.87 57.2  1.46 7.75  0.16 54 (32)
Hispanic 285 114.1  2.96 135.0  1.75† 70.9  0.81 64.1  1.36† 7.55  0.15 56 (20)†††
Women 140 113.7  3.67 136.8  2.18‡‡ 67.0  1.01 69.8  1.69‡‡ 7.46  0.18 22 (16)‡
Men 145 114.5  3.59 133.0  2.12 74.7  0.99 58.4  1.64 7.69  0.18 34 (24)
Chinese 109 107.6  4.07 128.4  2.41 72.3  1.12 56.1  1.87 7.24  0.21 36 (34)
Women 52 108.9  5.49 130.9  3.24 68.9  1.50 61.9  92.50 7.54  0.29 13 (26)
Men 57 106.3  5.06 125.8  2.99 75.6  1.39 50.2  2.31 7.04  0.25 23 (41)
DataaremeansSEorn(%).A1Cwasfromexam2.Comparisonswereadjustedasfollows:womenvs.menadjustedforage,site,race/ethnicity,income,education
level, and health insurance (government-sponsored vs. private vs. no insurance). African American vs. NHW adjusted for the same variables without race/ethnicity
and including sex, similarly for Hispanic vs. NHW and Chinese vs. NHW. African American women vs. NHW women adjusted for same variables without sex and
race/ethnicity, similarly for Hispanic women vs. NHW women and Chinese women vs. NHW women. *P  0.0001 for comparisons of women vs. men. †P  0.05,
††P  0.01, †††P  0.0001 for comparisons of African American, Hispanic, and Chinese vs. NHW. ‡P  0.05, ‡‡P  0.01 for comparisons of African American,
Hispanic, and Chinese women vs. NHW women.
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also have inﬂuenced treatment patterns
becauseexamresultswerereportedtothe
participants. Despite these limitations,
our ﬁndings provide new information
about sex and sex-speciﬁc race/ethnicity
differences in cardiovascular risk factor
treatment and control among individuals
with diabetes in a contemporary multi-
ethnic cohort with diverse sources of
insurance.
In conclusion, we found that among
subjects with diabetes in MESA, women
had unfavorable cardiovascular risk fac-
tor proﬁles compared with men at base-
line exam; however, these differences
diminished over time. African American
and Hispanic women had less favorable
proﬁles than NHW women.
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